XML 72 R56.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue and Accounts Receivable Credit Concentration - Summary of Revenue (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Disaggregation Of Revenue [Line Items]    
Revenues $ 49,087 $ 38,212
Diagnostic Tests    
Disaggregation Of Revenue [Line Items]    
Revenues 45,192 34,538
Biopharma Services and Other    
Disaggregation Of Revenue [Line Items]    
Revenues $ 3,895 $ 3,674